ResMed Inc. vs Johnson & Johnson
RMD vs JNJ — side-by-side comparison from reported financials. RMD leads 5, JNJ leads 5 of 10 comparable metrics.
ResMed Inc.
RMD · Healthcare
$230.05+1.46%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | RMD | JNJ |
|---|---|---|
| Price | $230.05 | $261.79 |
| Market cap | $32.4B | $631B |
| Revenue (TTM) | $5.65B | $97.9B |
| Revenue growth | +10.2% | +5.6% |
| Net margin | 26.9% | 21.5% |
| Free cash flow | $1.65B | $22.2B |
| Net cash (debt) | $643M | ($27.8B) |
| 1-year price return | -17.2% | +37.0% |
| P/E | 21.2 | 29.9 |
| P/E vs own history (cheap-side %) | 91% | 16% |
| Dividend yield | 1.08% | 2.00% |
| Return on equity | 24% | 26% |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 11,370 | 140,800 |
Full résumé-style profiles: RMD CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.